MLT also reduces the synthesis of IL-6 and NO during LPS-induced endotoxemia by blocking the NF-κB signaling pathway, thereby blocking its nuclear translocation and DNA binding of the NF-κB p50 subunit and suppressing STAT-1 signaling [56]. The gene discussed is STAT1; the disease is serum lipopolysaccharide activity.